Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Dec ‘22 |
|
|---|---|---|---|---|---|
| $3.86M | $6.88M | $3.02M | 102% |
|
|
| $3.81M | $6.07M | $2.26M | 89.7% |
|
|
| $3.79M | $4.1M | $308K | 77% |
|
|
79
Arcturus Therapeutics
ARCT
$241M
| $3.68M | $6.67M | $2.99M | 50.1% |
|
| $3.58M | $12.2M | $8.58M | 74.1% |
|
|
| $3.57M | $17.3M | $13.7M | 14.1% |
|
|
| $3.5M | $3.84M | $338K | 72.1% |
|
|
| $3.43M | $3.58M | $153K | 11.4% |
|
|
| $3.2M | $3.92M | $717K | 44.7% |
|
|
| $3.11M | $3.33M | $215K | 1.56% |
|
|
|
BCTX
86
Briacell Therapeutics
BCTX
$27M
| $3.08M | $3.2M | $116K | 99.4% |
|
| $3.06M | $4.53M | $1.47M | 59.6% |
|
|
| $3.04M | $8.61M | $5.57M | 86.7% |
|
|
| $2.91M | $3.44M | $527K | 52.8% |
|
|
| $2.86M | $3.09M | $233K | 30.6% |
|
|
| $2.81M | $49.1M | $46.3M | 67.3% |
|
|
| $2.69M | $4.18M | $1.49M | 59.7% |
|
|
| $2.62M | $2.62M | $5K | 11.3% |
|
|
| $2.49M | $2.61M | $124K | 60% |
|
|
| $2.42M | $4.27M | $1.84M | 99.9% |
|
|
| $2.36M | $2.93M | $571K | 33.7% |
|
|
| $2.3M | $2.32M | $18K | 29.7% |
|
|
| $2.23M | $2.47M | $240K | 47.9% |
|
|
| $2.22M | $2.22M | $0 | 23.5% |
|
|
| $2.2M | $2.62M | $416K | 62.4% |
|